Texas Defective Drugs Attorney

Defective Drugs Attorney Corpus Christi TX

A Defective Drugs Lawyer at Herrman & Herrman, P.L.L.C., Can Help You

Large, high-profile drug manufacturers often put profits over safety. Whether through negligence or intentional acts, they introduce drugs into the marketplace that are harmful and deadly. In many cases, the defect is not discovered until someone is seriously injured or someone has passed away.

Taking immediate action is vital in proving that a drug is defective. The attorneys at Herrman & Herrman, P.L.L.C., combine experience and legal knowledge with dedication and diligence in their handling of complex personal injury claims.

When a so-called “safe” drug is discovered to be dangerous due to side effects or interactions with other medication, immediate action must be taken. Contact us at our Corpus Christi office at (361)792-2358 or our McAllen office at (956)622-4200.

Zofran Risks and Lawsuits: What You Need to Know

If you or a loved one has or has had cancer, you may have heard of the drug Zofran. Zofran is a medication that has been authorized to be used against nausea resulting from cancer treatments. It has, in some cases, also been used to treat nausea associated with pregnancy, although it has not received explicit FDA approval for this purpose. Zofran has recently been alleged to cause congenital disabilities in children born from those prescribed Zofran. For this reason, lawsuits have been filed against the manufacturers of Zofran.

Zofran and Birth Defects

Since Zofran’s release, Zofran reports causing congenital disabilities in the children born from people using Zofran. These congenital disabilities include structural heart defects, cleft lips, and cleft palates, and cranial defects. These congenital disabilities can be deeply damaging to a newborn and can be extremely costly for medical care. Not only do these birth defects cause medical expenses, but they can also be emotionally and physically draining on the family of the newborn who is afflicted.

Zofran Lawsuits

Since the birth defects have been widely alleged and reported, there have been numerous lawsuits filed against the drug makers of Zofran. Currently, there is an active lawsuit against GlaxoSmithKline, a pharmaceutical company responsible for Zofran. The lawsuit alleges that GlaxoSmithKline marketed Zofran as a safe and effective treatment for morning sickness and nausea associated with pregnancy. The lawsuit alleges that GlaxoSmithKline was aware of congenital disabilities’ potential and unethically promoted the drug anyway. This would mean that the pharmaceutical company is guilty of negligence.

What Should I Do if I Believe My Child has suffered a Birth Defect as a Result of Zofran?

If you have had a child born with a birth defect after being on Zofran—prescribed or not—you should contact a reputable attorney in your area. A personal injury attorney with knowledge of the Zofran case will help you as you pursue compensation.

[INFOGRAPHIC] Drug Recalls A to Z


Zantac Recalls Due to Cancer Risks: What to Know

Zantac is a popular medication that treats heartburn and acid reflux. However, the FDA ordered in April 2020 that manufacturers and distributors pull the drug from shelves and cease prescribing it. The FDA found that this medication and the over-the-counter generic version ranitidine contained significant NDMA, a probable carcinogen. Zantac and ranitidine have been linked to the development of cancers, specifically stomach, liver, and bladder cancers.

Zantac and NDMA

The FDA found that Zantac pills contain unsafe amounts of NDMA (N-nitrosodimethylamine), an organic compound that is probably carcinogenic to humans. Experimental lab results show that NDMA is carcinogenic to animals. NDMA is associated with a wide range of cancers, including liver cancer, throat cancer, lung cancer, stomach cancer, bladder cancer, cancer of the kidney or renal cancer, leukemia, and lymphomas.

Alternatives to Zantac

Suppose you have been using Zantac or ranitidine for treatment of heartburn or excess stomach acid. In that case, it is advisable to stop consumption of the medication and talk with your doctor about other options. The FDA has recommended several alternative drugs that have not been shown to contain NDMA, including Pepcid, Nexium, Tagamet, Prevacid, and Prilosec. Each of these medicines may be effective in reducing your heartburn or stomach acid production.

What Should I Do if I Believe My Cancer is a Result of Zantac?

If you or a loved one developed one of the cancers linked to NDMA and you suspect that treatment with Zantac may have been involved, you may have legal options. Lawsuits have already been filed against several drugmakers, including Sanofi, on the basis that drug makers had a duty to the public to warn them of potential risk. If you’ve developed cancer and you have incurred exorbitant expenses or quality of life decrease, as a result, contact an experienced personal injury attorney in your area. An attorney familiar with Zantac and other drug-related negligence cases will be able to help you win the compensation you deserve.

Previous Information About Zantac

Pharmacists in Connecticut discovered that the drug Zantac (generic ranitidine) contained a cancer-causing ingredient called Nitrosodimethylamine, or NDMA in some of the batches of the drug. The medication has since been recalled and pulled from the shelves of retailers like Walmart, Walgreens, and CVS. Zantac is a medication used to treat heartburn and stomach ulcers, though certain production batches containing NDMA could cause quite the opposite effect on your body. Since consuming these batches of Zantac, some customers have been diagnosed with bladder, stomach, and liver cancers.

An Update On The Lawsuit

In 2020, the Zantac lawsuit info has been evolving quickly. As of April 2020, the Food and Drug Administration, or FDA, has advised that Zantac and its generics be removed from retail circulation and manufacturing altogether. The FDA also called the drug a “public health risk” due to its carcinogenic ingredients. It has also been claimed that the manufacturers of Zantac knew about the potentially carcinogenic ingredient inclusion, which would mean that their inaction could qualify as negligence. Currently, there are class action lawsuits filed by attorneys in the states of New Jersey, California, Florida, Connecticut, and Massachusetts. These lawsuits have only to do with negligence, however, and those involved only have to prove that they purchased the Zantac medication and did not receive a warning about the potential inclusion of NDMA.

How A Dangerous Drug Attorney Should Handle Dangerous Drug Litigation

Upon taking a defective drug case, we begin a thorough investigation into the injury or death suffered and how the tragedy occurred. “Black box” warning label information on the packaging listing side effects provides a certain amount of protection for the manufacturer. However, additional negative reactions could occur as well. Some clients come to us having taken a drug before any side effects were noted.

Our network of medical experts helps us get to the facts of a defective drug case. Fact-finding cannot only hold manufacturers accountable but also maximize compensation for our clients, putting them on the road to recovery.

Contact our Texas defective drugs attorney today for a no obligation free consultation.

For more information or to schedule an appointment with an experienced Texas product liability lawyer regarding a defective drug claim, please contact us first!

Our firm has offices in the following locations: Corpus Christi, Corpus Christi South Side, Brownsville, McAllen, San Antonio, Houston, and Ft. Worth, TX.